149 related articles for article (PubMed ID: 31360464)
1. Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with
Sharma-Kuinkel BK; Tkaczyk C; Bonnell J; Yu L; Tovchigrechko A; Tabor DE; Park LP; Ruffin F; Esser MT; Sellman BR; Fowler VG; Ruzin A
Clin Transl Immunology; 2019; 8(7):e01070. PubMed ID: 31360464
[TBL] [Abstract][Full Text] [Related]
2. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
3. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
4. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
5. Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of
den Reijer PM; Tavakol M; Lemmens-den Toom N; Allouch D; Thomas S; Ganesh VK; Ko YP; Verbrugh HA; van Wamel WJB
mSphere; 2018; 3(2):. PubMed ID: 29564394
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.
Wu Y; Liu X; Akhgar A; Li JJ; Mok H; Sellman BR; Yu L; Roskos LK; Esser MT; Ruzin A
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263109
[No Abstract] [Full Text] [Related]
7. Distinct virulent network between healthcare- and community-associated
He L; Meng H; Liu Q; Hu M; Wang Y; Chen X; Liu X; Li M
Clin Proteomics; 2018; 15():2. PubMed ID: 29321722
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.
Verkaik NJ; Boelens HA; de Vogel CP; Tavakol M; Bode LG; Verbrugh HA; van Belkum A; van Wamel WJ
Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):509-18. PubMed ID: 20186449
[TBL] [Abstract][Full Text] [Related]
9. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
Lalani T; Federspiel JJ; Boucher HW; Rude TH; Bae IG; Rybak MJ; Tonthat GT; Corey GR; Stryjewski ME; Sakoulas G; Chu VH; Alder J; Steenbergen JN; Luperchio SA; Campion M; Woods CW; Fowler VG
J Clin Microbiol; 2008 Sep; 46(9):2890-6. PubMed ID: 18596141
[TBL] [Abstract][Full Text] [Related]
10. Distribution of virulence genes in bacteremic methicillin-resistant Staphylococcus aureus isolates from various sources.
Wang FD; Wu PF; Chen SJ
J Microbiol Immunol Infect; 2019 Jun; 52(3):426-432. PubMed ID: 30686615
[TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
Shorr AF; Zilberberg MD; Micek ST; Kollef MH
Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
[TBL] [Abstract][Full Text] [Related]
12. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
Schreiber MP; Chan CM; Shorr AF
J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
[TBL] [Abstract][Full Text] [Related]
13. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia.
Theprungsirikul J; Thaden JT; Wierzbicki RM; Burns AS; Skopelja-Gardner S; Fowler VG; Winthrop KL; Martin IW; Rigby WFC
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747603
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
15. Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB.
Thomsen IP; Dumont AL; James DB; Yoong P; Saville BR; Soper N; Torres VJ; Creech CB
Infect Immun; 2014 Mar; 82(3):1234-42. PubMed ID: 24379282
[TBL] [Abstract][Full Text] [Related]
16. Immunobiology of methicillin-resistant Staphylococcus aureus: immune response of rabbits and patients to systemic infection.
Traub WH; Bauer D; Leonhard B
Chemotherapy; 1996; 42(2):118-32. PubMed ID: 8697887
[TBL] [Abstract][Full Text] [Related]
17. Antibody response in patients with endocarditis caused by Staphylococcus aureus.
Rindi S; Cicalini S; Pietrocola G; Venditti M; Festa A; Foster TJ; Petrosillo N; Speziale P
Eur J Clin Invest; 2006 Aug; 36(8):536-43. PubMed ID: 16893375
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
19. Genotypic and Phenotypic Characterization of
Lacoma A; Laabei M; Sánchez-Herrero JF; Young B; Godoy-Tena G; Gomes-Fernandes M; Sumoy L; Plans O; Arméstar F; Prat C
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562023
[No Abstract] [Full Text] [Related]
20. Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against
Ruzin A; Wu Y; Yu L; Yu XQ; Tabor DE; Mok H; Tkaczyk C; Jensen K; Bellamy T; Roskos L; Esser MT; Jafri HS
Clin Transl Immunology; 2018; 7(1):e1009. PubMed ID: 29484186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
